US congressman moves to bar politicians from prediction markets
A new US bill seeks to bar politicians and federal staff from trading prediction market contracts tied to policy and politics.
Todas as matérias desta categoria, das mais recentes às mais antigas.
A new US bill seeks to bar politicians and federal staff from trading prediction market contracts tied to policy and politics.
Ascentage Pharma (NASDAQ:AAPG) shares were in focus on Tuesday, January 6, 2026, following the announcement that the U.S. FDA has cleared its Investigational New Drug (IND) application for APG-3288.
8x8 (NASDAQ:EGHT), a global leader in integrated cloud communications, announced on Tuesday, January 6, 2026, that it has acquired Maven Lab, a Singapore-based specialist in mobile marketing and enterprise messaging.
The acquisition is a strategic "step-change" for 8x8, designed to cement its leadership in the high-growth Asia-Pacific (APAC) customer engagement market.
By integrating Maven Lab’s team and its acclaimed Moobidesk platform into the 8x8 Platform for CX, the company is pivoting from traditional messaging toward "orchestrated, omnichannel customer journeys."
Moobidesk offers a unified interface for SMS, WhatsApp, Viber, LINE, and voice, featuring smart AI routing and automated response suggestions that have been shown to increase sales leads by an average of 10% for its enterprise clients.
The move comes as the CPaaS (Communications Platform as a Service) market is projected to grow from $32 billion today to nearly $100 billion by 2030.
With Maven Lab’s deep local carrier relationships and regional expertise, 8x8 is now uniquely positioned to support mission-critical, high-volume communications for the finance, healthcare, and logistics sectors across Southeast Asia.
HUTCHMED (China) Limited (NASDAQ:HCM) shares climbed in after-hours trading Wednesday after the company announced that its novel Syk inhibitor, sovleplenib, met the primary endpoint in the Phase III registration portion of the ESLIM-02 trial.
Baidu (NASDAQ:BIDU) announced on Wednesday, January 7, 2026, that its autonomous ride-hailing platform, Apollo Go, has received Dubai’s first-ever permit for fully driverless vehicle trials on public roads.
Caracas and Washington have agreed to send up to $2 billion worth of Venezuelan crude to U.S. refineries, a move that could reroute supply away from China.
Marvell Technology said on Tuesday it will buy networking equipment provider XConn Technologies in a deal worth about $540 million, as the chipmaker doubles down on data center hardware amid a race to expand artificial intelligence infrastructure.
Ford Motor Company (NYSE:F) reported robust U.S. sales results for the fourth quarter and full year 2025, with Q4 sales rising 2.7% year-over-year and annual sales climbing 6% to approximately 2.2 million vehicles.
Johnson & Johnson (NYSE:JNJ) announced on Tuesday, January 6, 2026, that its Phase 2b JASMINE study of nipocalimab in adults with moderate-to-severe systemic lupus erythematosus (SLE) met its primary and key secondary endpoints.
Zai Lab Limited (NASDAQ:ZLAB) announced on January 6, 2026, that China’s National Medical Products Administration (NMPA) has approved the supplemental New Drug Application (sNDA) for AUGTYRO™ (repotrectinib).
This approval targets adult patients with advanced or metastatic solid tumors harboring a neurotrophic tyrosine receptor kinase (NTRK) gene fusion.
In a significant victory for food transparency advocates, a federal appeals court ruled on January 6, 2026, in favor of Natural Grocers (NASDAQ:NGVC), the Center for Food Safety, and a coalition of plaintiffs.
Abpro Holdings (NASDAQ:ABP) and South Korean biopharma giant Celltrion announced on January 6, 2026, that the U.S. FDA has cleared the Investigational New Drug (IND) application for ABP-102 (CT-P72).
This clearance transitions Abpro’s lead oncology program into the clinic, targeting a wide array of HER2-positive solid tumors, including breast, gastric, colorectal, and pancreatic cancers.
Tem um segundo para um cookie? 🍪Os cookies essenciais mantêm a Grafa funcionando bem. Alguns opcionais nos ajudam a ver o que está funcionando para melhorarmos. Você tem o controle — pode mudar de ideia quando quiser. Política de cookies · Política de privacidade